Watch the full video on YouTube to hear Prof. Hindrik Mulder, editor-in-chief of Diabetologia, reflect on the scientific clinical and societal forces shaping the future of diabetes research.
In this episode, we explore:
Breakthroughs in hypoimmune stem cell-based therapies and beta cell replacement
Why scalability and access are critical for real-world impact
Research inequities, diversity, and global disparities in diabetes care
The importance of heterogeneity in type 1 and type 2 diabetes
How patient voices are influencing study design and publication priorities and
The launch of Metabologia – EASD’s new journal and sister journal to Diabetologia on metabolic diseases
Start the year with insights from the editor’s desk and discover what’s next in diabetes research.
Explore Prof. Mulder’s profile and the Diabetologia Symposium from the EASD Annual Meeting 2025:
Prof. Hindrik Mulder
Diabetologia Symposium
For more conversations with leading voices in diabetes research, visit our podcast archive
